@WHO: WHO’s #COVID19 Solidarity clinical trial enters a new phase - Solidarity PLUS - with three new candidate drugs: -artesunate -imatinib -infliximab 👉 https://t.co/K6tk22NnFf

http://twitter.com/WHO
via IFTTT